Dean Falb retweeted
This week we will be at the 2nd Annual @HDDSummit in Boston, where on Thursday our CSO, Dean Falb, will be speaking about LogicBio’s advancements on treatments for pediatric patients with #hemophilia. #HDDSummit #HemophiliaDrugDevelopment
Dean Falb retweeted
Today our CEO @fred_chereau will be presenting at the @ASGCTherapy pre-meeting Gene Editing Workshop from 5:50-6:00pm in the Lincoln Room. #ASGCT19
Dean Falb retweeted
Our lead program in development for patients with methylmalonic acidemia, LB-001, has just received FDA orphan drug designation. This milestone brings us one step closer to our goal of genome editing to treat pediatric rare diseases. More here: bit.ly/2IPwuf8
Dean Falb retweeted
Our co-founder Mark Kay is on stage at @alliancerm now, kicking off the Cell & Gene Therapy Investor Day with a conversation about the new frontiers of genome editing and gene therapy.
Dean Falb retweeted
LogicBio is hiring at all levels! Learn more about our open positions and collaborative working culture here: bit.ly/2u1qw1u
Dean Falb retweeted
The LogicBio team is in Miami for the @Barclays Global Healthcare Conference! We are looking forward to meeting with all of the biotechnology industry leaders in attendance to explore and exchange ideas.
Dean Falb retweeted
Our goal is to deliver genetic therapies to pediatric patients living with rare diseases. We are grateful to #RareDiseaseDay for raising awareness of the strength of these patients and the urgent need to develop new treatments.
Dean Falb retweeted
Jim Collins is kicking off our discussion this evening at @labcentral about #synbio specifically living therapies.
Thanks @johncumbers for convening this!
@Ginkgo @synlogic_tx to follow. Reminds me of good ol’ days with @vitherapharma !
Dean Falb retweeted
Today we are pleased to announce that Kenneth Huttner, M.D., Ph.D., has joined our leadership team as Senior Vice President, Head of Clinical Development. We're thrilled to have you, Ken! Read the full release here: bit.ly/2GWlPxC
Dean Falb retweeted
We're collaborative. We're driven. We're passionate. And every member of our team is empowered to make an impact. Interested in joining the LogicBio team? View our open positions here: bit.ly/2POnqXX
Dean Falb retweeted
Thanks Dr. Paul Miller (employee #1 pictured here with founders @DeanFalb, Jim Collins & CEO @aoifemlbrennan) for his many contributions to @synlogic_tx’s success! We wish him all the best in his new venture back home in Connecticut! Delighted that he will join @synlogic_tx SAB!
Dean Falb retweeted
As we move our genome editing technology toward the clinic, we are focusing initially on metabolic diseases, starting with methylmalonic acidemia. Learn about one family’s story living with this devastating genetic disease on our new patient focus page: bit.ly/2F6HSkV
Dean Falb retweeted
A busy and exciting year ahead for the @synlogic_tx team and our collaborators. Synlogic Progresses Clinical and Preclinical Pipeline and Outlines 2019 Catalysts | Business Wire businesswire.com/news/home/2…
